Public Release: 

Cell Press launches a new open-access journal, Cell Reports

Renowned publisher introduces premium-quality open-access journal

Cell Press

Cell Press reinforces its commitment to provide a broad range of publishing options for the life sciences community with the inaugural issue of a new open-access journal: Cell Reports. Since the announcement in August, after 6 months of hard work on the part of our authors, reviewers, and editorial board members as well as our own editorial and production teams, the first issue is available online today, January 26, 2011, with eight exciting papers on topics ranging from evolutionary biology to immunology.

"We are thrilled to add Cell Reports to the Cell Press family of journals, giving choice to our authors and readers and providing a new avenue for communicating cutting-edge science." said Dr. Emilie Marcus, CEO of Cell Press. "Cell Reports brings all the features scientists have come to expect from Cell Press--exciting science, highest quality content, editorial responsiveness, and rapid publication--together with a broad biological scope, a short report format, and an open-access business model."

Leading the Cell Reports editorial team is Dr. Boyana Konforti, who brings a wealth of experience from a successful research career and over 13 years as a professional editor. Support from Cell Press editors as well as an actively engaged editorial board ensures broad expertise across an extensive range of topics. With a focus on concise, provocative stories and a professional approach to the entire publication process, Cell Reports will make a distinctive contribution to open-access publishing.

The launch of Cell Reports is the next step in Cell Press's ongoing dedication to serving the scientific community. Cell Press has always placed a high priority on enabling authors to disseminate published research widely and easily and offers a variety of options to make content universally accessible. The Cell Press open-archive policy, enacted in 2005, allows readers to access all online research journal content free of charge from 12 months after publication. This policy now provides a resource of over 24,000 articles that are freely available online. Newly-published featured articles are also available online at no charge on a monthly basis. On behalf of authors, Cell Press has voluntarily deposited over 7,200 of the total 84,863 Elsevier contribution of research papers into PubMed Central databases over the past 5 years. Cell Press continues to partner proactively with institutions, government agencies, and funding bodies to facilitate access to research. Cell Press and Elsevier also participate in a wide range of worldwide initiatives to provide low-cost or free access to scientific information to teachers, healthcare patients and providers, as well as researchers with limited resources. In addition, subscribing libraries are able to offer free access to walk-in users.

Through Cell Reports, Cell Press is happy to provide authors with the option to publish in a prestigious journal with immediate open access. Authors can choose to publish their work under one of two Creative Commons licenses, one of which is the most liberal available. Cell Press and Elsevier share an ongoing commitment to promote access to the scientific literature and to support a broad range of sustainable publishing models.

###

For more information on Cell Reports, please visit http://cellreports.cell.com/

About Cell Press:

Cell Press is committed to improving scientific communication through the publication of exciting research and reviews. As we introduce publications and expand our online content to serve our growing audience, our mission remains to publish and develop journals that deliver the highest possible intellectual rigor, promote community trust, and are widely disseminated. Cell Press primary research journals include the flagship journal Cell. For more information, please visit www.cell.com

About Elsevier:

Elsevier is a world-leading publisher of scientific, technical, and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier publishes eight open-access journals and offers authors the option to sponsor open access to articles published in over 1,100 titles. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult, and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK, and ENL (New York Stock Exchange).

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.